Capital Investment Advisors, LLC

Source: SEC Form 13F · as of Mar 2026

Capital Investment Advisors, LLC holds 29 biotech & pharma companies tracked by BioSniper, totaling $659.1M in value as of Mar 2026 (SEC Form 13F).

Companies held

29

Total value held

$659.1M

CompanySharesValue
JNJJOHNSON & JOHNSON828,010$202.4M
ABBVAbbVie Inc.660,858$143.7M
MRKMerck & Co., Inc.739,564$89.0M
LLYELI LILLY & Co54,842$50.4M
GILDGILEAD SCIENCES, INC.194,404$27.1M
CAHCardinal Health Inc.120,662$25.5M
BMYBRISTOL MYERS SQUIBB CO409,146$24.8M
PMPhilip Morris International Inc145,850$24.1M
PFEPFIZER INC845,840$23.8M
AMGNAMGEN INC31,596$11.1M
UNHUnitedHealth Group Incorporated Common Stock (DE)37,442$10.1M
MCKMcKesson Corporation7,328$6.3M
INSMINSMED Inc26,490$4.3M
ZTSZoetis Inc.30,504$3.6M
ABTABBOTT LABORATORIES23,591$2.4M
DGXQuest Diagnostics Incorporated6,024$1.2M
VRTXVERTEX PHARMACEUTICALS INC / MA2,606$1.2M
AUPHAurinia Pharmaceuticals Inc.77,730$1.2M
GMOptec International, Inc.13,248$987K
NVSNovartis AG6,242$953K
GEHCGE HealthCare Technologies Inc.12,412$883K
REGNREGENERON PHARMACEUTICALS, INC.1,138$879K
BIIBBIOGEN INC.4,174$765K
CORCencora Inc.2,287$718K
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)8,890$491K
NVONovo Nordisk A/S12,004$441K
ELVElevance Health Inc.1,154$338K
IBRXImmunityBio, Inc.43,474$333K
TSHATaysha Gene Therapies, Inc.20,000$89K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.

    Capital Investment Advisors, LLC — Biotech 13F Holdings & Portfolio | BioSniper